Molecular analysis of the PAX6 gene in Mexican patients with congenital aniridia: report of four novel mutations
2008

Study of PAX6 Gene Mutations in Mexican Aniridia Patients

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): Villarroel Camilo E., Villanueva-Mendoza Cristina, Orozco Lorena, Alcántara-Ortigoza Miguel Angel, Jiménez Diana F., Ordaz Juan C., González-del Angel Ariadna

Primary Institution: National Institute of Pediatrics, Mexico City, Mexico

Hypothesis

This study aims to analyze PAX6 variants in Mexican aniridia patients and describe associated ocular findings.

Conclusion

The study identifies four novel mutations in the PAX6 gene and confirms that c.969C>T is a frequent causal mutation in aniridia cases.

Supporting Evidence

  • The study identified eight different mutations in the PAX6 gene.
  • Four of these mutations were novel and not previously reported.
  • The mutation detection rate was found to be 30%.
  • Most cases exhibited severe phenotypes with associated ocular alterations.

Takeaway

The researchers looked at the genes of 30 Mexican children with a condition called aniridia, which affects their eyes, and found some new changes in their genes that could help explain why they have this condition.

Methodology

The study evaluated 30 unrelated aniridia probands using mutation detection techniques including SSCP and direct sequencing.

Limitations

The mutation detection rate of 30% is lower than expected, possibly due to the limitations of the SSCP technique and not analyzing regulatory sequences.

Participant Demographics

Participants were 30 unrelated Mexican patients with congenital aniridia, with a median age of 5.2 years and 62% female.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication